Literature DB >> 9261441

The rapid spread of recombinants during a natural in vitro infection with two human immunodeficiency virus type 1 strains.

T Kuwata1, Y Miyazaki, T Igarashi, J Takehisa, M Hayami.   

Abstract

We quantified a population of recombinants in a natural in vitro infection, using wild-type viruses without any pressure. It was found that recombinants emerged early after infection and constituted more than 20% of the whole proviral population 15 days after infection. Furthermore, recombinants were isolated as infectious viruses by simple limiting dilution. These results imply that, in addition to the high mutation rate of human immunodeficiency virus type 1 (HIV-1), recombination among HIV-1 strains plays a significant part in the development of the high diversity of HIV-1.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9261441      PMCID： PMC192002     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  28 in total

1.  Homologous recombination of copackaged retrovirus RNAs during reverse transcription.

Authors:  H Stuhlmann; P Berg
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Retroviral recombination and reverse transcription.

Authors:  W S Hu; H M Temin
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

3.  Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination.

Authors:  W S Hu; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro.

Authors:  S Delassus; R Cheynier; S Wain-Hobson
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

5.  DNA recombination during PCR.

Authors:  A Meyerhans; J P Vartanian; S Wain-Hobson
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

6.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

7.  The accuracy of reverse transcriptase from HIV-1.

Authors:  J D Roberts; K Bebenek; T A Kunkel
Journal:  Science       Date:  1988-11-25       Impact factor: 47.728

8.  Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group.

Authors:  R S Diaz; E C Sabino; A Mayer; J W Mosley; M P Busch
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Molecular cloning and characterization of a German HIV-1 isolate.

Authors:  U Sauermann; J Schneider; J Mous; U Brunckhorst; I Schedel; K D Jentsch; G Hunsmann
Journal:  AIDS Res Hum Retroviruses       Date:  1990-06       Impact factor: 2.205

10.  In vivo sequence variation of the human immunodeficiency virus type 1 env gene: evidence for recombination among variants found in a single individual.

Authors:  R M Howell; J E Fitzgibbon; M Noe; Z J Ren; D J Gocke; T A Schwartzer; D T Dubin
Journal:  AIDS Res Hum Retroviruses       Date:  1991-11       Impact factor: 2.205
View more
  15 in total

1.  Comparison of the genetic recombination rates of human immunodeficiency virus type 1 in macrophages and T cells.

Authors:  Jianbo Chen; Terence D Rhodes; Wei-Shau Hu
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments.

Authors:  Johan Vingerhoets; Hilde Azijn; Els Fransen; Inky De Baere; Liesbet Smeulders; Dirk Jochmans; Koen Andries; Rudi Pauwels; Marie-Pierre de Béthune
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events.

Authors:  Terence D Rhodes; Olga Nikolaitchik; Jianbo Chen; Douglas Powell; Wei-Shau Hu
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon.

Authors:  J Takehisa; L Zekeng; E Ido; Y Yamaguchi-Kabata; I Mboudjeka; Y Harada; T Miura; L Kaptu; M Hayami
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E.

Authors:  J P Anderson; A G Rodrigo; G H Learn; A Madan; C Delahunty; M Coon; M Girard; S Osmanov; L Hood; J I Mullins
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication.

Authors:  Terence Rhodes; Heather Wargo; Wei-Shau Hu
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms.

Authors:  Miguel E Quiñones-Mateu; Yong Gao; Sarah C Ball; Andre J Marozsan; Awet Abraha; Eric J Arts
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Evidence for recombination in the envelope gene of maedi-visna virus.

Authors:  Valgerdur Andrésdóttir
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

9.  In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.

Authors:  A Van Den Broeke; C Bagnis; M Ciesiolka; Y Cleuter; H Gelderblom; P Kerkhofs; P Griebel; P Mannoni; A Burny
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 10.  The remarkable frequency of human immunodeficiency virus type 1 genetic recombination.

Authors:  Adewunmi Onafuwa-Nuga; Alice Telesnitsky
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.